sellWeak cluster of 2
Rami Elghandour sold $10M of ACLX
SEE REMARKS at Arcellx, Inc.. 89,916 shares at an average of $113.92, traded Feb 27, 2026, filed Feb 27, 2026.
Warning score
38Value
$10M
89,916 shares
Holdings after
276,051
-25% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$10.2M at market
- +5Share of holdings soldSold 25% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001193125-26-083657, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | MOption exercise Common Stock | +55,459 | $0.00 | $0 | 673,378 | Feb 27, 2026 |
| Jan 3, 2026 | MOption exercise Common Stock | +53,098 | $0.00 | $0 | 726,476 | Feb 27, 2026 |
| Jan 6, 2026 | MOption exercise Common Stock | +55,991 | $0.00 | $0 | 782,467 | Feb 27, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock | -89,916 | $113.92 | $10M | 276,051 | Feb 27, 2026 |
Related signals
Other insiders at Arcellx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $1.3M 11,219 shares | -25% | |
| 39Weak | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $573k 8,384 shares | -16% | |
| 42Moderate | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $785k 11,291 shares | -17% | |
| 10Weak | Arcellx, Inc. | David Charles Lubner director | $450k 6,000 shares | -22% | |
| 29Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $403k 5,882 shares | -20% | |
| 31Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $487k 7,437 shares | -20% | |
| 29Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $393k 6,131 shares | -14% | |
| 20Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $31k 340 shares | -54% | |
| 30Weak | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $488k 5,364 shares | -39% | |
| 38Weak | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $512k 5,946 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.